Results 121 to 130 of about 49,464 (141)

Capecitabine

Reactions Weekly, 2013
openaire   +2 more sources

Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer

Annals of Oncology, 2003
Virginia Ferraresi, Diana Giannarelli, M Zeuli   +2 more
exaly  

Randomised phase III trial of vinflunine plus capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with an anthracycline and resistant to taxane

Annals of Oncology, 2018
Miguel Martin, Mario Campone, Igor N. Bondarenko   +2 more
exaly  

Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma

Annals of Oncology, 2009
Y J Bang, T Y Kim, S A Im
exaly  

A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer

Annals of Oncology, 2005
W W Ten Bokkel Huinink, N Steven, D J Richel   +2 more
exaly  

Capecitabine

Reactions Weekly, 2014
openaire   +2 more sources

Lower dose capecitabine has a more favorable therapeutic index in metastatic breast cancer: retrospective analysis of patients treated at M. D. Anderson Cancer Center and a review of capecitabine toxicity in the literature

Annals of Oncology, 2005
Vicente Valero
exaly  

Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine

Annals of Oncology, 2011
Antonello Vidiri, Stefania Gori, Giulio Metro   +2 more
exaly  

Capecitabine

Reactions Weekly, 2017
openaire   +1 more source

Multicenter phase II study of oral capecitabine (Xeloda“) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy

Annals of Oncology, 2003
P C Thuss-Patience, P Reichardt, D G Kieback   +2 more
exaly